Literature DB >> 3028347

Superoxide initiates oxidation of low density lipoprotein by human monocytes.

K Hiramatsu, H Rosen, J W Heinecke, G Wolfbauer, A Chait.   

Abstract

Human mononuclear cells were used to evaluate the role of superoxide in the oxidation of low density lipoprotein (LDL). Unstimulated cells produced little superoxide or LDL oxidation as assayed by lipid peroxide content. Stimulation of the cells with phorbol myristate acetate (PMA) resulted in an increase both in superoxide production and in LDL oxidation. Mononuclear cell-mediated LDL oxidation was time- and cell number-dependent and was markedly enhanced by the presence of Fe (10 microM). Superoxide was required for the initiation of LDL oxidation as indicated by inhibition of the reaction by early addition of superoxide dismutase (SOD). Propagation of LDL oxidation was superoxide-independent, since the later addition of SOD resulted in progressively less inhibition of LDL oxidation. Propagation of LDL oxidation also was, in part, cell-independent as indicated by continued oxidation of LDL when mononuclear cells were removed following a 1 to 8 hour period with cells. Optimal LDL oxidation required the presence of mononuclear cells throughout the incubation period, suggesting that cellular factors in addition to superoxide play a role in LDL oxidation. Further evidence for the role of superoxide in the oxidation of LDL by mononuclear cells was obtained with cells from patients with genetic deficiencies of either superoxide generation (chronic granulomatous disease) or myeloperoxidase. PMA-stimulated cells from a patient with chronic granulomatous disease neither generated superoxide nor modified LDL. Incubation of LDL with cells from a patient with myeloperoxidase deficiency (in which superoxide production is normal or increased) resulted in oxidation of the lipoprotein equivalent to that observed with normal cells. Other inhibitors of oxidation reactions also were tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028347     DOI: 10.1161/01.atv.7.1.55

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  28 in total

1.  Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.

Authors:  O Jaakkola; T Nikkari
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Cellular oxidative modification of low density lipoprotein does not require lipoxygenases.

Authors:  C P Sparrow; J Olszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 3.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

4.  Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells.

Authors:  S A Thorne; S E Abbot; P G Winyard; D R Blake; P G Mills
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

5.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

Authors:  S Christen; S R Thomas; B Garner; R Stocker
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 7.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

Review 8.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

9.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study.

Authors:  S Agarwal; A V Rao
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.